Orteronel

DB12066InvestigationalSmall molecule

Orteronel has been investigated for the treatment of Prostate Cancer.

Mechanism: Pharmacologically active on Steroid 17-alpha-hydroxylase/17,20 lyase
Curator reviewed
Formula / weight: C₁₈H₁₇N₃O₂ · 307.353 g/mol (avg)
Code names: TAK-700

Resolves to

Compound

Structure

InChIKeyOZPFIJIOIVJZMN-SFHVURJKSA-NSMILESCNC(=O)C1=CC=C2C=C(C=CC2=C1)[C@@]1(O)CCN2C=NC=C12

Targets

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

14Clinical trialsPhase, status and sponsor resolved per trial

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with Orteronel, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.